← FDA Drug Approvals (Drugs@FDA)

CLOBETASOL PROPIONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 2024-03-14

Drug application

FDA Application #

ANDA208563

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLOBETASOL PROPIONATE

Generic name

Clobetasol Propionate

Active ingredients

CLOBETASOL PROPIONATE

Dosage form

AEROSOL, FOAM

Route

TOPICAL

Marketing status

Discontinued

Sponsor

TARO

First approval

2024-03-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown